Healing Opioid misuse and Pain through Engagement (HOPE) Study
Researchers at the University of New Mexico are partnering with individuals who are prescribed buprenorphine to look at the benefits of a treatment for opioid use and chronic pain.
Research Study Key Details
Prescribed Buprenorphine for Opioid Use
Experience Chronic Pain
Compensation Provided
Conducted Remotely in New Mexico and Michigan
Study Background
We’re seeking ways to manage pain for people who have chronic pain and opioid use disorder.
This is a research study on a treatment called Acceptance and Commitment Therapy plus Mindfulness-Based Relapse Prevention (ACT+MBRP). The goal is to see if this treatment effectively reduces pain interference – meaning how much your pain negatively affects your life – in people who have chronic pain and are prescribed buprenorphine for opioid use.
Eventually, the findings of this study might be useful for dealing with chronic pain and improving people’s quality of life.
Study Background
We’re seeking ways to manage pain for people who have chronic pain and opioid use disorder.
This is a research study on a treatment called Acceptance and Commitment Therapy plus Mindfulness-Based Relapse Prevention (ACT+MBRP). The goal is to see if this treatment effectively reduces pain interference – meaning how much your pain negatively affects your life – in people who have chronic pain and are prescribed buprenorphine for opioid use.
Eventually, the findings of this study might be useful for dealing with chronic pain and improving people’s quality of life.
Additional Information
Opioids are often prescribed to treat chronic pain, but for people with opioid use disorder, other options are needed. The aim of this study is to look at the benefits of a treatment for opioid use and chronic pain.
You may qualify for a study if you meet the following criteria.
Inclusion Criteria:
- 18+ years old
- Prescribed buprenorphine for opioid use
- Experience chronic pain
- Chronic pain has lasted at least 3 months
- Reside in New Mexico or Michigan
- No diagnosis of schizophrenia, delusional disorder, psychotic, or dissociative disorder
- No substance use disorder other than opioids
- Able to read English
The entire study lasts about 15 months. All parts of the study can be completed remotely. If you decide to join the study, you will be asked to:
- Complete several surveys over the course of one year
Complete a 3-month treatment consisting of 12 weekly sessions or an individual interview
As a participant, you can receive up to $500 for your time and effort.
There is no cost for you to participate in our research study.
